Currently, hyperbaric oxygen therapy is a valuable hospital tool for diabetics with chronic non-healing wounds and is a therapy that is reserved for late stages of diabetics. With recent literature supporting the use of HBOT for earlier onset, this new study gives us further hope that hyperbaric oxygen should be used for early stage diabetes and not just reserved for later stages. Here, it was shown that obese, diabetic rats given HBOT enhanced glucose and lipid metabolism in the skeletal muscle. Since obesity runs rampant in the diabetic population, and the concomitant effects of blood sugar elevation damaging the small blood vessels of the body, HBOT may prove as a valuable resource for diabetics, not only for its aid in cardiovascular disease and wound healing support, but for also lowering the levels of blood sugar; thereby, causing less damage in the body <view study>